期刊文献+

周围静脉畸形MMP-9表达与临床分型的相关性研究

Relationship between MMP-9 expression and the sub-types of peripheral venous malformations
下载PDF
导出
摘要 目的:分析周围静脉畸形组织中基质金属蛋白酶MMP-9的表达情况,研究其与周围静脉畸形临床分型的关系,初步探讨静脉畸形的发病机制。方法:对51例周围静脉畸形和10例正常微小静脉组织行免疫组织化学染色,观察并分析:①MMP-9及TIMP-1在周围静脉畸形与正常组织中的表达;②MMP-9与周围静脉畸形临床分型的关系;③MMP-9及TIMP-1在周围静脉畸形中表达的相关性。结果:MMP-9在周围静脉畸形中的表达率为82.35%,明显高于正常微小静脉组织(P=0.0002),在各分型中的表达有明显差异(P=0.0300),在有浸润与无浸润组的表达中有显著性差异(P=0.0043);TIMP-1在周围静脉畸形中的表达率为54.90%,与正常组织无明显差异(P=0.0842),与MMP-9的表达有差异(P=0.0145),但两者无明显正相关性(γs=0.3404)。结论:MMP-9在静脉畸形中的表达明显上调,在不同临床分型中的表达有明显差异,特别是在浸润型中呈明显高表达;MMP-9可作为静脉畸形临床诊断的参考指标,以及本研究临床分型的依据之一;MMP-9/TIMP-1平衡关系的破坏,可能是静脉畸形呈进行性生长的发病机制之一。 Objective To investigate the relationship between the expression of matrix metalloproteinase-9 (MMP- 9) and the sub-types of peripheral venous malformations. Methods MMP-9 and TIMP-1 expression were detected by immunohistochemical staining in 10 specimens of normal micro-veins and 51 specimens of peripheral venous malformation specimens. The relationship between the MMP-9 and TIMP-1 expression in venous malformations was analyzed. Results The expression rate of MMP-9 in venous malformation tissues was 82.35%, much higher than that of the normal microveins(P=0.0002). MMP-9 expression was significantly different among various sub-types of peripheral venous malformations (P=0.03); it was predominantly higher in subtypes with tissue invasion(P=0.0043).The expression rate of TIMP-1 in venous malformation tissues was 54.90%, which was similar to that in normal tissues(P=0.0842). No obvious relationship was found between MMP-9 and TIMP-1 expression (γa=0.3404). Conclusions MMP-9 is overexpressed in venous malformations, especially in sub-types with tissue invasion.Therefore, MMP-9 might be served as a diagnostic and sub-typing parameter of venous malformation. The disturbance of MMP-9 and TIMP-1 balance may lead to the progression of venous malformation.
出处 《外科理论与实践》 2007年第4期367-372,共6页 Journal of Surgery Concepts & Practice
关键词 基质金属蛋白酶 静脉 畸形 免疫组织化学 Matrix metalloproteinases Veins Abnormalities Immunohistochemistry Clinical classification
  • 相关文献

参考文献15

  • 1蒋米尔,张培华.血管外科发展的挑战和机遇[J].外科理论与实践,2004,9(1):1-2. 被引量:15
  • 2刘晓兵,黄新天,黄英,陆信武,李维敏,殷敏毅,陆民,蒋米尔.周围静脉畸形281例手术治疗分析[J].外科理论与实践,2005,10(1):30-34. 被引量:5
  • 3Hara I,Miyake H,Hara S,et al.Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder[J].J Urol,2001,165(5):1769-1772.
  • 4蒋米尔,黄英.血管外科实验研究的发展方向[J].中华实验外科杂志,2004,21(4):391-394. 被引量:10
  • 5Loukopoulos P,Mungall BA,Straw RC,et al.Matrix metalloproteinase-2 and-9 involvement in canine tumors[J].Vet Pathol,2003,40(4):382-394.
  • 6Cheung PY,Sawicki G,Wozniak M,et al.Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart[J].Circulation,2000,101(15):1833-1839.
  • 7Galis ZS,Johnson C,Godin D,et al.Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling[J].Circ Res,2002,91(9):852-859.
  • 8Goodall S,Crowther M,Hemingway DM,et al.Ubiquitous elevation of matrix metalloproteinase-2 expression in the vaseulature of patients with abdominal aneurysms[J].Circulation,2001,104(3):304-309.
  • 9Loftus IM,Naylor AR,Goodall S,et al.Increased matrix metalloproteinase-9 activity in unstable carotid plaques.A potential role in acute plaque disruption[J].Stroke,2000,31(1):40-47.
  • 10Jacob MP,Cazaubon M,Scemama A,et al.Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veinsPlasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins[J].Circulation,2002,106(5):535-538.

二级参考文献7

  • 1Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics [J]. Plast Reconstr Surg, 1982,69(3):412-422.
  • 2Jackson IT,Carreno R,Potparic Z,et al. Hemangiomas,vascular malformations,and lymphovenous malformations :classification and methods of treatment[J].Plast Reconstr Surg,1993,91 (7): 1216-1230.
  • 3Waner M, Suen JY. Hemangiomas and vascular malformations of the head and neck[M]. New York:Wiley-Liss,Inc,1999,82-92.
  • 4Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations [J]. J Vasc Interv Radiol,2004,15(5):431-445.
  • 5Mathes EF, Haggstrom AN, Dowd C,et al. Clinical characteristics and management of vascular anomalies: findings of a multidisciplinary vascular anomalies clinic [J].Arch Dermatol, 2004,140(8):979-983.
  • 6David LR ,Malek MM, Argenta LC. Efficacy of pulse dye laser therapy for the treatment of ulcerated heamangiomas: a review of 78 patients [J]. Br J Plast Surg ,2003,56(4):317-327.
  • 7黄新天,蒋米尔,周国瑜,陆民,朱雯霞,陆信武,李维敏,黄英,张培华.手术联合Nd:YAG激光治疗弥漫性海绵状血管瘤22例报告[J].中国实用外科杂志,2002,22(3):165-166. 被引量:13

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部